New developments in the induction and antiviral effectors of type I interferon

Current Opinion in Immunology

Volumn 23, Issue 1, 2011, Pages 57-64

  Liu, Su Yang ^a   Sanchez, David Jesse ^a   Cheng, Genhong ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; BETA INTERFERON; CELL PROTEIN; GUANOSINE TRIPHOSPHATASE; INTEREFERON STIMULATED GENE 15; INTERFERON; INTERFERON INDUCED TRANSMEMBRANE PROTEIN 1; INTERFERON INDUCED TRANSMEMBRANE PROTEIN 2; INTERFERON INDUCED TRANSMEMBRANE PROTEIN 3; TOLL LIKE RECEPTOR 2; UNCLASSIFIED DRUG; VIPERIN;

ANTIVIRAL ACTIVITY; CYTOKINE RELEASE; DNA BINDING; DNA VIRUS; INFLUENZA VIRUS; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN MODIFICATION; PROTEIN PROCESSING; REVIEW; VIRUS ENTRY; VIRUS GENOME; VIRUS INFECTION; VIRUS RELEASE; VIRUS REPLICATION;

ANIMALS; DNA, VIRAL; HUMANS; INTERFERON TYPE I; TOLL-LIKE RECEPTOR 2; TRANSCRIPTION, GENETIC; VIRUS DISEASES;

EID: 79951671973     PISSN: 09527915     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.coi.2010.11.003     Document Type: Review

References (59)

1. Kawai T., Akira S. Toll-like receptor and RIG-1-like receptor signaling. Ann N Y Acad Sci 2008, 1143:1-20.
2. Baum A., García-Sastre A. Induction of type I interferon by RNA viruses: cellular receptors and their substrates. Amino Acids 2010, 38:1283-1299.
3. Yang P., An H., Liu X., Wen M., Zheng Y., Rui Y., Cao X. The cytosolic nucleic acid sensor LRRFIP1 mediates the production of type I interferon via a [beta]-catenin-dependent pathway. Nat Immunol 2010, 11:487-494.
4. Stadeli R., Hoffmans R., Basler K. Transcription under the control of nuclear arm/[beta]-catenin. Curr Biol 2006, 16:R378-R385.
5. Takaoka A., Wang Z., Choi M.K., Yanai H., Negishi H., Ban T., Lu Y., Miyagishi M., Kodama T., Honda K., et al. DAI (DLM-1/ZBP1) is a cytosolic DNA sensor and an activator of innate immune response. Nature 2007, 448:501-505.
6. Wang Z., Choi M.K., Ban T., Yanai H., Negishi H., Lu Y., Tamura T., Takaoka A., Nishikura K., Taniguchi T. Regulation of innate immune responses by DAI (DLM-1/ZBP1) and other DNA-sensing molecules. Proceedings of the National Academy of Sciences 2008, 105:5477-5482.
7. Ishikawa H., Barber G.N. STING is an endoplasmic reticulum adaptor that facilitates innate immune signalling. Nature 2008, 455:674-678.
8. Ishikawa H., Ma Z., Barber G.N. STING regulates intracellular DNA-mediated, type I interferon-dependent innate immunity. Nature 2009, 461:788-792.
9. Chiu Y., MacMillan J.B., Chen Z.J. RNA polymerase III detects cytosolic DNA and induces type I interferons through the RIG-I pathway. Cell 2009, 138:576-591.
10. Barbalat R., Lau L., Locksley R.M., Barton G.M. Toll-like receptor 2 on inflammatory monocytes induces type I interferon in response to viral but not bacterial ligands. Nat Immunol 2009, 10:1200-1207.
11. Haller O., Staeheli P., Kochs G. Interferon-induced Mx proteins in antiviral host defense. Biochimie 2007, 89:812-818.
12. Sadler A.J., Williams B.R.G. Interferon-inducible antiviral effectors. Nat Rev Immunol 2008, 8:559-568.
13. Hovanessian A.G. On the discovery of interferon-inducible, double-stranded RNA activated enzymes: The 2'-5'oligoadenylate synthetases and the protein kinase PKR. Cytokine & Growth Factor Reviews 2007, 18:351-361.
14. Brass A.L., Huang I., Benita Y., John S.P., Krishnan M.N., Feeley E.M., Ryan B.J., Weyer J.L., van der Weyden L., Fikrig E., et al. The IFITM proteins mediate cellular resistance to influenza A H1N1 virus, West Nile virus, and Dengue virus. Cell 2009, 139:1243-1254.
15. Yount J.S., Moltedo B., Yang Y., Charron G., Moran T.M., López C.B., Hang H.C. Palmitoylome profiling reveals S-palmitoylation-dependent antiviral activity of IFITM3. Nat Chem Biol 2010, 6:610-614.
16. Durfee L.A., Lyon N., Seo K., Huibregtse J.M. The ISG15 conjugation system broadly targets newly synthesized proteins: implications for the antiviral function of ISG15. Mol Cell 2010, 38:722-732.
17. Shi H., Yang K., Liu X., Liu X., Wei B., Shan Y., Zhu L., Wang C. Positive regulation of interferon regulatory factor 3 activation by Herc5 via ISG15 modification. Mol Cell Biol 2010, 30:2424-2436.
18. Okumura A., Pitha P.M., Harty R.N. ISG15 inhibits Ebola VP40 VLP budding in an l-domain-dependent manner by blocking Nedd4 ligase activity. Proc Natl Acad Sci USA 2008, 105:3974-3979.
19. Hsiang T., Zhao C., Krug R.M. Interferon-induced ISG15 conjugation inhibits influenza A virus gene expression and replication in human cells. J Virol 2009, 83:5971-5977.
20. Zhao C., Hsiang T., Kuo R., Krug R.M. ISG15 conjugation system targets the viral NS1 protein in influenza A virus-infected cells. Proc Natl Acad Sci USA 2010, 107:2253-2258.
21. Tang Y., Zhong G., Zhu L., Liu X., Shan Y., Feng H., Bu Z., Chen H., Wang C. Herc5 attenuates influenza A virus by catalyzing ISGylation of viral NS1 protein. J Immunol 2010, 184:5777-5790.
22. Wang X., Hinson E.R., Cresswell P. The interferon-inducible protein Viperin inhibits influenza virus release by perturbing lipid rafts. Cell Host Microbe 2007, 2:96-105. This study to show mechanism of Viperin inhibition on influenza through changes in membrane integrity.
23. Miyanari Y., Atsuzawa K., Usuda N., Watashi K., Hishiki T., Zayas M., Bartenschlager R., Wakita T., Hijikata M., Shimotohno K. The lipid droplet is an important organelle for hepatitis C virus production. Nat Cell Biol 2007, 9:1089-1097.
24. Jiang D., Guo H., Xu C., Chang J., Gu B., Wang L., Block T.M., Guo J. Identification of three interferon-inducible cellular enzymes that inhibit the replication of hepatitis C virus. J Virol 2008, 82:1665-1678.
25. Shaveta G., Shi J., Chow V.T., Song J. Structural characterization reveals that viperin is a radical S-adenosyl-l-methionine (SAM) enzyme. Biochem Biophys Res Commun 2010, 391:1390-1395.
26. Haller O., Stertz S., Kochs G. The Mx GTPase family of interferon-induced antiviral proteins. Microbes and Infection 2007, 9:1636-1643.
27. Taylor G.A., Feng C.G., Sher A. p47 GTPases: regulators of immunity to intracellular pathogens. Nat Rev Immunol 2004, 4:100-109.
28. Carlow D.A., Teh S., Teh H. Specific antiviral activity demonstrated by TGTP, a member of a new family of interferon-induced GTPases. J Immunol 1998, 161:2348-2355.
29. Zhang H.M., Yuan J., Cheung P., Luo H., Yanagawa B., Chau D., Stephan-Tozy N., Wong B.W., Zhang J., Wilson J.E., et al. Overexpression of interferon-γ-inducible GTPase inhibits coxsackievirus B3-induced apoptosis through the activation of the phosphatidylinositol 3-kinase/akt pathway and inhibition of viral replication. J Biol Chem 2003, 278:33011-33019.
30. Anderson S.L., Carton J.M., Lou J., Xing L., Rubin B.Y. Interferon-induced guanylate binding protein-1 (GBP-1) mediates an antiviral effect against vesicular stomatitis virus and encephalomyocarditis virus. Virology 1999, 256:8-14.
31. Itsui Y., Sakamoto N., Kakinuma S., Nakagawa M., Sekine-Osajima Y., Tasaka-Fujita M., Nishimura-Sakurai Y., Suda G., Karakama Y., Mishima K., et al. Antiviral effects of the interferon-induced protein guanylate binding protein 1 and its interaction with the hepatitis C virus NS5B protein. Hepatology 2009, 50:1727-1737.
32. Gorbacheva V.Y., Lindner D., Sen G.C., Vestal D.J. The interferon (IFN)-induced GTPase, mGBP-2. J Biol Chem 2002, 277:6080-6087.
33. Prakash B., Praefcke G.J.K., Renault L., Wittinghofer A., Herrmann C. Structure of human guanylate-binding protein 1 representing a unique class of GTP-binding proteins. Nature 2000, 403:567-571.
34. Carter C.C., Gorbacheva V.Y., Vestal D.J. Inhibition of VSV and EMCV replication by the interferon-induced GTPase, mGBP-2: differential requirement for wild-type GTP binding domain. Arch Virol 2005, 150:1213-1220.
35. Meurs E.F., Watanabe Y., Kadereit S., Barber G.N., Katze M.G., Chong K., Williams B.R., Hovanessian A.G. Constitutive expression of human double-stranded RNA-activated p68 kinase in murine cells mediates phosphorylation of eukaryotic initiation factor 2 and partial resistance to encephalomyocarditis virus growth. J Virol 1992, 66:5805-5814.
36. Lee S.B., Esteban M. The interferon-induced double-stranded RNA-activated human p68 protein kinase inhibits the replication of vaccinia virus. Virology 1993, 193:1037-1041.
37. Muto N.F., Martinand-Mari C., Adelson M.E., Suhadolnik R.J. Inhibition of replication of reactivated human immunodeficiency virus type 1 (HIV-1) in latently infected U1 cells transduced with an HIV-1 long terminal repeat-driven PKR cDNA construct. J Virol 1999, 73:9021-9028.
38. Balachandran S., Roberts P.C., Brown L.E., Truong H., Pattnaik A.K., Archer D.R., Barber G.N. Essential role for the dsRNA-dependent protein kinase PKR in innate immunity to viral infection. Immunity 2000, 13:129-141.
39. Leib D.A., Machalek M.A., Williams B.R.G., Silverman R.H., Virgin H.W. Specific phenotypic restoration of an attenuated virus by knockout of a host resistance gene. Proc Natl Acad Sci USA 2000, 97:6097-6101.
40. Lin R., Yu H., Chang B., Tang W., Liao C., Lin Y. Distinct antiviral roles for human 2′,5′-oligoadenylate synthetase family members against dengue virus infection. J Immunol 2009, 183:8035-8043.
41. Silverman R.H. Viral encounters with 2′,5′-oligoadenylate synthetase and RNase L during the interferon antiviral response. J Virol 2007, 81:12720-12729.
42. Stremlau M., Owens C.M., Perron M.J., Kiessling M., Autissier P., Sodroski J. The cytoplasmic body component TRIM5[alpha] restricts HIV-1 infection in Old World monkeys. Nature 2004, 427:848-853.
43. Berthoux L., Sebastian S., Sokolskaja E., Luban J. Lv1 inhibition of human immunodeficiency virus type 1 is counteracted by factors that stimulate synthesis or nuclear translocation of viral cDNA. J Virol 2004, 78:11739-11750.
44. Wu X., Anderson J.L., Campbell E.M., Joseph A.M., Hope T.J. Proteasome inhibitors uncouple rhesus TRIM5α restriction of HIV-1 reverse transcription and infection. Proc Natl Acad Sci USA 2006, 103:7465-7470.
45. Pion M., Granelli-Piperno A., Mangeat B., Stalder R., Correa R., Steinman R.M., Piguet V. APOBEC3G/3F mediates intrinsic resistance of monocyte-derived dendritic cells to HIV-1 infection. J Exp Med 2006, 203:2887-2893.
46. Bogerd H.P., Wiegand H.L., Doehle B.P., Lueders K.K., Cullen B.R. APOBEC3A and APOBEC3B are potent inhibitors of LTR-retrotransposon function in human cells. Nucleic Acids Res 2006, 34:89-95.
47. Harris R.S., Bishop K.N., Sheehy A.M., Craig H.M., Petersen-Mahrt S.K., Watt I.N., Neuberger M.S., Malim M.H. DNA deamination mediates innate immunity to retroviral infection. Cell 2003, 113:803-809.
48. Strebel K., Luban J., Jeang K. Human cellular restriction factors that target HIV-1 replication. BMC Med 2009, 7:48.
49. Bishop K.N., Holmes R.K., Malim M.H. Antiviral potency of APOBEC proteins does not correlate with cytidine deamination. J Virol 2006, 80:8450-8458.
50. Li X., Guo F., Zhang L., Kleiman L., Cen S. APOBEC3G inhibits DNA strand transfer during HIV-1 reverse transcription. J Biol Chem 2007, 282:32065-32074.
51. Mbisa J.L., Bu W., Pathak V.K. APOBEC3F and APOBEC3G inhibit HIV-1 DNA integration by different mechanisms. J Virol 2010, 84:5250-5259.
52. Strebel K., Khan M. APOBEC3G encapsidation into HIV-1 virions: which RNA is it?. Retrovirology 2008, 5:55.
53. Okumura A., Lu G., Pitha-Rowe I., Pitha P.M. Innate antiviral response targets HIV-1 release by the induction of ubiquitin-like protein ISG15. Proc Natl Acad Sci USA 2006, 103:1440-1445.
54. Lenschow D.J., Lai C., Frias-Staheli N., Giannakopoulos N.V., Lutz A., Wolff T., Osiak A., Levine B., Schmidt R.E., García-Sastre A., et al. IFN-stimulated gene 15 functions as a critical antiviral molecule against influenza, herpes, and Sindbis viruses. Proc Natl Acad Sci USA 2007, 104:1371-1376.
55. Espert L., Degols G., Lin Y., Vincent T., Benkirane M., Mechti N. Interferon-induced exonuclease ISG20 exhibits an antiviral activity against human immunodeficiency virus type 1. J Gen Virol 2005, 86:2221-2229.
56. Espert L., Degols G., Gongora C., Blondel D., Williams B.R., Silverman R.H., Mechti N. ISG20, a new interferon-induced RNase specific for single-stranded RNA, defines an alternative antiviral pathway against RNA genomic viruses. J Biol Chem 2003, 278:16151-16158.
57. Chin K., Cresswell P. Viperin (cig5), an IFN-inducible antiviral protein directly induced by human cytomegalovirus. Proc Natl Acad Sci USA 2001, 98:15125-15130.
58. Helbig K.J., Lau D.T., Semendric L., Harley H.A.J., Beard M.R. Analysis of ISG expression in chronic hepatitis C identifies viperin as a potential antiviral effector. Hepatology 2005, 42:702-710.
59. Rivieccio M.A., Suh H., Zhao Y., Zhao M., Chin K.C., Lee S.C., Brosnan C.F. TLR3 ligation activates an antiviral response in human fetal astrocytes: a role for viperin/cig5. J Immunol 2006, 177:4735-4741.